Rank | Gene Set | Z-score |
---|---|---|
1 | synaptic vesicle maturation (GO:0016188) | 5.62810296 |
2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.37493746 |
3 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.29005060 |
4 | synaptic vesicle exocytosis (GO:0016079) | 4.97278430 |
5 | locomotory exploration behavior (GO:0035641) | 4.84483704 |
6 | glutamate secretion (GO:0014047) | 4.77395627 |
7 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.59664159 |
8 | cerebellar granule cell differentiation (GO:0021707) | 4.57850283 |
9 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.56465716 |
10 | vocalization behavior (GO:0071625) | 4.34788616 |
11 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.17867678 |
12 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.16150592 |
13 | regulation of synaptic vesicle transport (GO:1902803) | 4.10438349 |
14 | neuronal action potential propagation (GO:0019227) | 4.08314569 |
15 | protein localization to synapse (GO:0035418) | 4.05475868 |
16 | neurotransmitter secretion (GO:0007269) | 4.02087431 |
17 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.98886642 |
18 | postsynaptic membrane organization (GO:0001941) | 3.91271105 |
19 | cellular potassium ion homeostasis (GO:0030007) | 3.90954673 |
20 | exploration behavior (GO:0035640) | 3.82632064 |
21 | sodium ion export (GO:0071436) | 3.81704348 |
22 | L-amino acid import (GO:0043092) | 3.79346467 |
23 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.78968814 |
24 | regulation of synapse structural plasticity (GO:0051823) | 3.74313342 |
25 | layer formation in cerebral cortex (GO:0021819) | 3.68441660 |
26 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.67336001 |
27 | positive regulation of dendritic spine development (GO:0060999) | 3.63844745 |
28 | amino acid import (GO:0043090) | 3.63301380 |
29 | neuromuscular process controlling posture (GO:0050884) | 3.56517998 |
30 | gamma-aminobutyric acid transport (GO:0015812) | 3.50465145 |
31 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.49940637 |
32 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.48892812 |
33 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.48207029 |
34 | cell communication by electrical coupling (GO:0010644) | 3.47091508 |
35 | regulation of synapse maturation (GO:0090128) | 3.46016276 |
36 | neuron cell-cell adhesion (GO:0007158) | 3.44933905 |
37 | activation of protein kinase A activity (GO:0034199) | 3.40097611 |
38 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.35517082 |
39 | auditory behavior (GO:0031223) | 3.32254236 |
40 | synaptic transmission, glutamatergic (GO:0035249) | 3.31514914 |
41 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.28009207 |
42 | dendritic spine organization (GO:0097061) | 3.27486946 |
43 | neurotransmitter transport (GO:0006836) | 3.26465570 |
44 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.24380123 |
45 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.24170342 |
46 | positive regulation of neurotransmitter transport (GO:0051590) | 3.23400799 |
47 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.23339296 |
48 | response to pheromone (GO:0019236) | 3.22869784 |
49 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.21330623 |
50 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.20481186 |
51 | dendritic spine morphogenesis (GO:0060997) | 3.19971569 |
52 | central nervous system myelination (GO:0022010) | 3.19317373 |
53 | axon ensheathment in central nervous system (GO:0032291) | 3.19317373 |
54 | long-term memory (GO:0007616) | 3.19256987 |
55 | proline transport (GO:0015824) | 3.19034755 |
56 | glycine transport (GO:0015816) | 3.17200614 |
57 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.15220022 |
58 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.14721404 |
59 | glutamate receptor signaling pathway (GO:0007215) | 3.14055922 |
60 | neuron-neuron synaptic transmission (GO:0007270) | 3.14015627 |
61 | membrane depolarization during action potential (GO:0086010) | 3.12175977 |
62 | positive regulation of membrane potential (GO:0045838) | 3.12113373 |
63 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.09305025 |
64 | neuromuscular synaptic transmission (GO:0007274) | 3.07934830 |
65 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.06273762 |
66 | regulation of vesicle fusion (GO:0031338) | 3.05106588 |
67 | regulation of cell communication by electrical coupling (GO:0010649) | 3.05016604 |
68 | synaptic vesicle endocytosis (GO:0048488) | 3.04193302 |
69 | regulation of dendritic spine development (GO:0060998) | 3.03963169 |
70 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.01606120 |
71 | positive regulation of synapse maturation (GO:0090129) | 3.00808785 |
72 | regulation of neurotransmitter secretion (GO:0046928) | 3.00451668 |
73 | regulation of neurotransmitter levels (GO:0001505) | 2.99538564 |
74 | neuromuscular process controlling balance (GO:0050885) | 2.99419667 |
75 | regulation of synaptic plasticity (GO:0048167) | 2.98687405 |
76 | innervation (GO:0060384) | 2.98071074 |
77 | establishment of mitochondrion localization (GO:0051654) | 2.96600792 |
78 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.94926375 |
79 | potassium ion homeostasis (GO:0055075) | 2.91823586 |
80 | regulation of postsynaptic membrane potential (GO:0060078) | 2.91637599 |
81 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.91133838 |
82 | dendrite morphogenesis (GO:0048813) | 2.90646136 |
83 | potassium ion import (GO:0010107) | 2.89878713 |
84 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.87460690 |
85 | neuron recognition (GO:0008038) | 2.84813281 |
86 | acidic amino acid transport (GO:0015800) | 2.84578765 |
87 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.83316261 |
88 | long-term synaptic potentiation (GO:0060291) | 2.82902204 |
89 | synaptic vesicle transport (GO:0048489) | 2.80460886 |
90 | establishment of synaptic vesicle localization (GO:0097480) | 2.80460886 |
91 | vesicle transport along microtubule (GO:0047496) | 2.80087770 |
92 | regulation of ARF protein signal transduction (GO:0032012) | 2.80030767 |
93 | cellular sodium ion homeostasis (GO:0006883) | 2.79230490 |
94 | membrane hyperpolarization (GO:0060081) | 2.77281829 |
95 | mating behavior (GO:0007617) | 2.76473285 |
96 | regulation of neurotransmitter transport (GO:0051588) | 2.76289185 |
97 | transmission of nerve impulse (GO:0019226) | 2.75808175 |
98 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.75663610 |
99 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.75418841 |
100 | axonemal dynein complex assembly (GO:0070286) | 2.75070684 |
101 | neuronal ion channel clustering (GO:0045161) | 2.74988758 |
102 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.74383837 |
103 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.74380040 |
104 | cell differentiation in hindbrain (GO:0021533) | 2.74216643 |
105 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.74174106 |
106 | chemosensory behavior (GO:0007635) | 2.73375025 |
107 | cerebellar Purkinje cell layer development (GO:0021680) | 2.72832574 |
108 | cell communication involved in cardiac conduction (GO:0086065) | 2.72111544 |
109 | membrane depolarization (GO:0051899) | 2.71253668 |
110 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.70949415 |
111 | response to auditory stimulus (GO:0010996) | 2.70670033 |
112 | detection of calcium ion (GO:0005513) | 2.70603737 |
113 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.70072895 |
114 | cell migration in hindbrain (GO:0021535) | 2.66996351 |
115 | calcium ion-dependent exocytosis (GO:0017156) | 2.66781286 |
116 | axonal fasciculation (GO:0007413) | 2.64596869 |
117 | membrane repolarization (GO:0086009) | 2.62516470 |
118 | organelle transport along microtubule (GO:0072384) | 2.61386430 |
119 | neuromuscular process (GO:0050905) | 2.60648687 |
120 | synaptic transmission (GO:0007268) | 2.60562100 |
121 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.59860507 |
122 | axon cargo transport (GO:0008088) | 2.59524680 |
123 | prepulse inhibition (GO:0060134) | 2.59296502 |
124 | positive regulation of synaptic transmission (GO:0050806) | 2.56137298 |
125 | regulation of synaptic transmission (GO:0050804) | 2.55934519 |
126 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.54749747 |
127 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.54289946 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.98603876 |
2 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.83747330 |
3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.81322382 |
4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.62857034 |
5 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.61798161 |
6 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.54834547 |
7 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.53821214 |
8 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.52317084 |
9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.52238873 |
10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.52238873 |
11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.51198447 |
12 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.46652932 |
13 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.41383523 |
14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.30846169 |
15 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.30646629 |
16 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.30639565 |
17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.29548682 |
18 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.26957822 |
19 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.26733099 |
20 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.18807915 |
21 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.06839037 |
22 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.02913194 |
23 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.96723391 |
24 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.96577110 |
25 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.90180445 |
26 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.88825501 |
27 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.86578258 |
28 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.81022004 |
29 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.62717263 |
30 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.61255520 |
31 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.59941750 |
32 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.58877421 |
33 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.45357988 |
34 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.40192174 |
35 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.39688516 |
36 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.36168320 |
37 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.34772038 |
38 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.29590779 |
39 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.28331967 |
40 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.27790599 |
41 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.27728359 |
42 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.26945225 |
43 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.26858471 |
44 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.26726541 |
45 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.25599652 |
46 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.25302326 |
47 | KDM2B_26808549_Chip-Seq_K562_Human | 1.24774356 |
48 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.23528297 |
49 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.23283491 |
50 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.21636860 |
51 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.20878344 |
52 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.19331373 |
53 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.19160143 |
54 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.18726281 |
55 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.18038625 |
56 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.17945317 |
57 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.17265023 |
58 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.15641395 |
59 | AR_19668381_ChIP-Seq_PC3_Human | 1.15576140 |
60 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.15428318 |
61 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.14205313 |
62 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.10957815 |
63 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.10546287 |
64 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.10196177 |
65 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.08683202 |
66 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.07365764 |
67 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.06744500 |
68 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.05866410 |
69 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.03929297 |
70 | AR_25329375_ChIP-Seq_VCAP_Human | 1.02947609 |
71 | STAT3_23295773_ChIP-Seq_U87_Human | 1.01006199 |
72 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.00991366 |
73 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.00931681 |
74 | P68_20966046_ChIP-Seq_HELA_Human | 1.00905147 |
75 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.99969785 |
76 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.99830666 |
77 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 0.99303803 |
78 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.99133109 |
79 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.98634396 |
80 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.97729132 |
81 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.97708660 |
82 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.96548371 |
83 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95838309 |
84 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.95052238 |
85 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.94311121 |
86 | * P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.94175710 |
87 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.93959248 |
88 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.93387820 |
89 | P300_19829295_ChIP-Seq_ESCs_Human | 0.93246656 |
90 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.93081829 |
91 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.92905486 |
92 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.92895354 |
93 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.92765683 |
94 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.92686766 |
95 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.91780789 |
96 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.90246814 |
97 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.90081441 |
98 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.89941118 |
99 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.89185073 |
100 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.89108724 |
101 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88199467 |
102 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.88184628 |
103 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.87169512 |
104 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.86889803 |
105 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.86738585 |
106 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.86542957 |
107 | * TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.85032616 |
108 | * PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.85023513 |
109 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.84685397 |
110 | TCF4_23295773_ChIP-Seq_U87_Human | 0.84552302 |
111 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.84536024 |
112 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.84378925 |
113 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.83020242 |
114 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.82353707 |
115 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.82161055 |
116 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.81903868 |
117 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.81869838 |
118 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.81805931 |
119 | * KLF4_19829295_ChIP-Seq_ESCs_Human | 0.81622598 |
120 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.80786335 |
121 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.79661110 |
122 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.79074063 |
123 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.79036278 |
124 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.78364365 |
125 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.78059245 |
126 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.77491751 |
127 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.77044369 |
128 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.77016822 |
129 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76962850 |
130 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.76682944 |
131 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.76560877 |
132 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.76538801 |
133 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.75558938 |
134 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.74855492 |
135 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.73796688 |
136 | SA1_27219007_Chip-Seq_Bcells_Human | 0.73680953 |
137 | * SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.72149504 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 5.77348643 |
2 | MP0003880_abnormal_central_pattern | 3.89325490 |
3 | MP0004270_analgesia | 3.74500786 |
4 | MP0003635_abnormal_synaptic_transmissio | 3.66794966 |
5 | MP0009745_abnormal_behavioral_response | 2.87795068 |
6 | MP0002063_abnormal_learning/memory/cond | 2.86031449 |
7 | MP0002064_seizures | 2.81159848 |
8 | MP0001968_abnormal_touch/_nociception | 2.78075898 |
9 | MP0009046_muscle_twitch | 2.74825244 |
10 | MP0005423_abnormal_somatic_nervous | 2.68028107 |
11 | MP0002734_abnormal_mechanical_nocicepti | 2.53867936 |
12 | MP0002272_abnormal_nervous_system | 2.41440391 |
13 | MP0002572_abnormal_emotion/affect_behav | 2.37763647 |
14 | MP0002822_catalepsy | 2.28603680 |
15 | MP0001486_abnormal_startle_reflex | 2.27232944 |
16 | MP0002909_abnormal_adrenal_gland | 2.15644284 |
17 | MP0002735_abnormal_chemical_nociception | 2.11533855 |
18 | MP0002736_abnormal_nociception_after | 2.08335334 |
19 | MP0003329_amyloid_beta_deposits | 2.04336114 |
20 | MP0009780_abnormal_chondrocyte_physiolo | 2.03825574 |
21 | MP0002733_abnormal_thermal_nociception | 2.00037910 |
22 | MP0004858_abnormal_nervous_system | 1.94633868 |
23 | MP0001970_abnormal_pain_threshold | 1.86590171 |
24 | MP0001501_abnormal_sleep_pattern | 1.80040110 |
25 | MP0008569_lethality_at_weaning | 1.79541809 |
26 | MP0001440_abnormal_grooming_behavior | 1.79288808 |
27 | MP0001984_abnormal_olfaction | 1.78582401 |
28 | MP0002067_abnormal_sensory_capabilities | 1.78320950 |
29 | MP0002837_dystrophic_cardiac_calcinosis | 1.71454785 |
30 | MP0005551_abnormal_eye_electrophysiolog | 1.71220889 |
31 | MP0002184_abnormal_innervation | 1.70567211 |
32 | MP0005646_abnormal_pituitary_gland | 1.67699537 |
33 | MP0000751_myopathy | 1.67152658 |
34 | MP0006276_abnormal_autonomic_nervous | 1.66534964 |
35 | MP0004811_abnormal_neuron_physiology | 1.64239268 |
36 | MP0004145_abnormal_muscle_electrophysio | 1.53545186 |
37 | MP0000955_abnormal_spinal_cord | 1.53141147 |
38 | MP0002557_abnormal_social/conspecific_i | 1.52817170 |
39 | MP0000013_abnormal_adipose_tissue | 1.51833686 |
40 | MP0004924_abnormal_behavior | 1.50795493 |
41 | MP0005386_behavior/neurological_phenoty | 1.50795493 |
42 | MP0001502_abnormal_circadian_rhythm | 1.48604851 |
43 | MP0005645_abnormal_hypothalamus_physiol | 1.44802417 |
44 | MP0004885_abnormal_endolymph | 1.42857535 |
45 | MP0000778_abnormal_nervous_system | 1.41918857 |
46 | MP0002882_abnormal_neuron_morphology | 1.41747719 |
47 | MP0003879_abnormal_hair_cell | 1.33363392 |
48 | MP0002066_abnormal_motor_capabilities/c | 1.32722588 |
49 | MP0003633_abnormal_nervous_system | 1.31451437 |
50 | MP0008961_abnormal_basal_metabolism | 1.26576422 |
51 | MP0004142_abnormal_muscle_tone | 1.22619307 |
52 | MP0002229_neurodegeneration | 1.22590902 |
53 | MP0003122_maternal_imprinting | 1.20136698 |
54 | MP0002090_abnormal_vision | 1.14099243 |
55 | MP0004233_abnormal_muscle_weight | 1.10274054 |
56 | MP0003283_abnormal_digestive_organ | 1.09510888 |
57 | MP0006072_abnormal_retinal_apoptosis | 1.09092653 |
58 | MP0003631_nervous_system_phenotype | 1.07495883 |
59 | MP0003123_paternal_imprinting | 1.06423496 |
60 | MP0004043_abnormal_pH_regulation | 1.05488238 |
61 | MP0003634_abnormal_glial_cell | 1.02972900 |
62 | MP0001529_abnormal_vocalization | 0.99118291 |
63 | MP0002069_abnormal_eating/drinking_beha | 0.98459155 |
64 | MP0005535_abnormal_body_temperature | 0.97888266 |
65 | MP0004215_abnormal_myocardial_fiber | 0.96857123 |
66 | MP0004085_abnormal_heartbeat | 0.95397737 |
67 | MP0010386_abnormal_urinary_bladder | 0.94511738 |
68 | MP0002152_abnormal_brain_morphology | 0.94200151 |
69 | MP0000604_amyloidosis | 0.94131064 |
70 | MP0001905_abnormal_dopamine_level | 0.92254110 |
71 | MP0000747_muscle_weakness | 0.90198599 |
72 | MP0000920_abnormal_myelination | 0.88485763 |
73 | MP0005253_abnormal_eye_physiology | 0.88121660 |
74 | MP0003137_abnormal_impulse_conducting | 0.87022727 |
75 | MP0003690_abnormal_glial_cell | 0.86471630 |
76 | MP0004036_abnormal_muscle_relaxation | 0.84607882 |
77 | MP0002752_abnormal_somatic_nervous | 0.84060285 |
78 | MP0003075_altered_response_to | 0.83460602 |
79 | MP0004130_abnormal_muscle_cell | 0.83446750 |
80 | MP0002638_abnormal_pupillary_reflex | 0.83296643 |
81 | MP0003646_muscle_fatigue | 0.81743159 |
82 | MP0004147_increased_porphyrin_level | 0.81641115 |
83 | MP0002249_abnormal_larynx_morphology | 0.80321759 |
84 | MP0008874_decreased_physiological_sensi | 0.79666921 |
85 | MP0001348_abnormal_lacrimal_gland | 0.79649372 |
86 | MP0003787_abnormal_imprinting | 0.79377853 |
87 | MP0005167_abnormal_blood-brain_barrier | 0.79115683 |
88 | MP0003183_abnormal_peptide_metabolism | 0.78372836 |
89 | MP0003632_abnormal_nervous_system | 0.75387987 |
90 | MP0001346_abnormal_lacrimal_gland | 0.75119406 |
91 | MP0000749_muscle_degeneration | 0.74979140 |
92 | MP0008872_abnormal_physiological_respon | 0.74624213 |
93 | MP0001299_abnormal_eye_distance/ | 0.71497229 |
94 | MP0005623_abnormal_meninges_morphology | 0.70103118 |
95 | MP0002653_abnormal_ependyma_morphology | 0.69867771 |
96 | MP0004510_myositis | 0.69436633 |
97 | MP0005410_abnormal_fertilization | 0.67798254 |
98 | MP0004742_abnormal_vestibular_system | 0.67726350 |
99 | MP0000631_abnormal_neuroendocrine_gland | 0.67482871 |
100 | MP0001188_hyperpigmentation | 0.67158582 |
101 | MP0001963_abnormal_hearing_physiology | 0.65835030 |
102 | MP0002234_abnormal_pharynx_morphology | 0.65498870 |
103 | MP0000003_abnormal_adipose_tissue | 0.65304686 |
104 | MP0002269_muscular_atrophy | 0.63592628 |
105 | MP0000759_abnormal_skeletal_muscle | 0.63510788 |
106 | MP0005409_darkened_coat_color | 0.62989958 |
107 | MP0003172_abnormal_lysosome_physiology | 0.62507193 |
108 | MP0005620_abnormal_muscle_contractility | 0.62186088 |
109 | MP0000579_abnormal_nail_morphology | 0.61656525 |
110 | MP0001177_atelectasis | 0.61403712 |
111 | MP0002078_abnormal_glucose_homeostasis | 0.60829321 |
112 | MP0000566_synostosis | 0.60686791 |
113 | MP0001943_abnormal_respiration | 0.56854826 |
114 | MP0005394_taste/olfaction_phenotype | 0.56369602 |
115 | MP0005499_abnormal_olfactory_system | 0.56369602 |
116 | MP0004087_abnormal_muscle_fiber | 0.56357353 |
117 | MP0010769_abnormal_survival | 0.52588769 |
118 | MP0002332_abnormal_exercise_endurance | 0.51967335 |
119 | MP0001485_abnormal_pinna_reflex | 0.50524983 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Myokymia (HP:0002411) | 6.24088129 |
2 | Focal motor seizures (HP:0011153) | 5.65816843 |
3 | Visual hallucinations (HP:0002367) | 4.74257426 |
4 | Focal seizures (HP:0007359) | 4.61843648 |
5 | Action tremor (HP:0002345) | 4.01180222 |
6 | Epileptic encephalopathy (HP:0200134) | 3.88664234 |
7 | Progressive cerebellar ataxia (HP:0002073) | 3.77819305 |
8 | Supranuclear gaze palsy (HP:0000605) | 3.74217505 |
9 | Diplopia (HP:0000651) | 3.71448116 |
10 | Abnormality of binocular vision (HP:0011514) | 3.71448116 |
11 | Atonic seizures (HP:0010819) | 3.68474134 |
12 | Obstructive sleep apnea (HP:0002870) | 3.55047811 |
13 | Ankle clonus (HP:0011448) | 3.48407688 |
14 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.45307037 |
15 | Absence seizures (HP:0002121) | 3.45088574 |
16 | Febrile seizures (HP:0002373) | 3.40465444 |
17 | Generalized tonic-clonic seizures (HP:0002069) | 3.30761873 |
18 | Depression (HP:0000716) | 3.15997509 |
19 | Dialeptic seizures (HP:0011146) | 3.10088650 |
20 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.04343106 |
21 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.04343106 |
22 | Akinesia (HP:0002304) | 2.95535061 |
23 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.90531543 |
24 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.89769616 |
25 | Absent/shortened dynein arms (HP:0200106) | 2.89769616 |
26 | Anxiety (HP:0000739) | 2.88855556 |
27 | Postural instability (HP:0002172) | 2.85490602 |
28 | Central scotoma (HP:0000603) | 2.84803556 |
29 | Abnormal ciliary motility (HP:0012262) | 2.81547376 |
30 | Dysdiadochokinesis (HP:0002075) | 2.81545179 |
31 | Tetraplegia (HP:0002445) | 2.80294212 |
32 | Neurofibrillary tangles (HP:0002185) | 2.79541081 |
33 | Ventricular fibrillation (HP:0001663) | 2.78365518 |
34 | Annular pancreas (HP:0001734) | 2.76723201 |
35 | Pheochromocytoma (HP:0002666) | 2.74575503 |
36 | Torticollis (HP:0000473) | 2.73599909 |
37 | Abnormality of the lower motor neuron (HP:0002366) | 2.72348991 |
38 | Abnormal eating behavior (HP:0100738) | 2.71672093 |
39 | Dysmetria (HP:0001310) | 2.70733540 |
40 | Sleep apnea (HP:0010535) | 2.66447108 |
41 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.66388025 |
42 | Truncal ataxia (HP:0002078) | 2.63078522 |
43 | Poor eye contact (HP:0000817) | 2.61950912 |
44 | Rhinitis (HP:0012384) | 2.58018427 |
45 | Impaired social interactions (HP:0000735) | 2.56801659 |
46 | Abnormal social behavior (HP:0012433) | 2.56801659 |
47 | Cerebral hypomyelination (HP:0006808) | 2.56564498 |
48 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.55654644 |
49 | Hand muscle atrophy (HP:0009130) | 2.52791688 |
50 | Exercise-induced myalgia (HP:0003738) | 2.51530183 |
51 | Cerebral inclusion bodies (HP:0100314) | 2.50641051 |
52 | Focal dystonia (HP:0004373) | 2.49455108 |
53 | Spastic gait (HP:0002064) | 2.48177091 |
54 | Mutism (HP:0002300) | 2.46752666 |
55 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.45826431 |
56 | Upper limb amyotrophy (HP:0009129) | 2.44429922 |
57 | Distal upper limb amyotrophy (HP:0007149) | 2.44429922 |
58 | Broad-based gait (HP:0002136) | 2.42777179 |
59 | Peripheral hypomyelination (HP:0007182) | 2.42412961 |
60 | Hemiparesis (HP:0001269) | 2.40744862 |
61 | Gaze-evoked nystagmus (HP:0000640) | 2.40508680 |
62 | Genetic anticipation (HP:0003743) | 2.39723045 |
63 | Bundle branch block (HP:0011710) | 2.39386128 |
64 | Urinary urgency (HP:0000012) | 2.38622173 |
65 | Intention tremor (HP:0002080) | 2.37111304 |
66 | Congenital stationary night blindness (HP:0007642) | 2.36791292 |
67 | EEG with generalized epileptiform discharges (HP:0011198) | 2.34893160 |
68 | Epileptiform EEG discharges (HP:0011182) | 2.34408985 |
69 | Neuroendocrine neoplasm (HP:0100634) | 2.34204068 |
70 | Craniofacial dystonia (HP:0012179) | 2.29824486 |
71 | Scanning speech (HP:0002168) | 2.29738663 |
72 | Agitation (HP:0000713) | 2.29658619 |
73 | Apathy (HP:0000741) | 2.28862592 |
74 | Megalencephaly (HP:0001355) | 2.27990146 |
75 | Lower limb amyotrophy (HP:0007210) | 2.27920612 |
76 | Hypsarrhythmia (HP:0002521) | 2.25760979 |
77 | Hyperventilation (HP:0002883) | 2.22376471 |
78 | Amblyopia (HP:0000646) | 2.20832617 |
79 | Bradykinesia (HP:0002067) | 2.17049006 |
80 | Status epilepticus (HP:0002133) | 2.15053687 |
81 | Hemiplegia (HP:0002301) | 2.13494543 |
82 | Termporal pattern (HP:0011008) | 2.11936141 |
83 | Insidious onset (HP:0003587) | 2.11936141 |
84 | Foot dorsiflexor weakness (HP:0009027) | 2.08138748 |
85 | Lower limb muscle weakness (HP:0007340) | 2.07531683 |
86 | Papilledema (HP:0001085) | 2.07524815 |
87 | Diminished motivation (HP:0000745) | 2.07188727 |
88 | Prolonged QT interval (HP:0001657) | 2.06448569 |
89 | Muscle fiber splitting (HP:0003555) | 2.06223951 |
90 | Abnormality of macular pigmentation (HP:0008002) | 2.06036432 |
91 | Clonus (HP:0002169) | 2.02886030 |
92 | Hyporeflexia of lower limbs (HP:0002600) | 2.01150478 |
93 | Abnormal EKG (HP:0003115) | 2.00563128 |
94 | Drooling (HP:0002307) | 1.99479574 |
95 | Excessive salivation (HP:0003781) | 1.99479574 |
96 | Heart block (HP:0012722) | 1.98730405 |
97 | Abnormality of the foot musculature (HP:0001436) | 1.98339020 |
98 | Rapidly progressive (HP:0003678) | 1.95283581 |
99 | Polyphagia (HP:0002591) | 1.95282855 |
100 | Impaired smooth pursuit (HP:0007772) | 1.94374656 |
101 | Fetal akinesia sequence (HP:0001989) | 1.93636526 |
102 | Limb dystonia (HP:0002451) | 1.93395162 |
103 | Hypercortisolism (HP:0001578) | 1.93347581 |
104 | Insomnia (HP:0100785) | 1.92574315 |
105 | Dysmetric saccades (HP:0000641) | 1.92211737 |
106 | Scotoma (HP:0000575) | 1.91788094 |
107 | Spastic tetraparesis (HP:0001285) | 1.91631969 |
108 | Rigidity (HP:0002063) | 1.89706689 |
109 | Neoplasm of the heart (HP:0100544) | 1.89187306 |
110 | Abnormal atrioventricular conduction (HP:0005150) | 1.88358504 |
111 | Progressive inability to walk (HP:0002505) | 1.87577499 |
112 | Failure to thrive in infancy (HP:0001531) | 1.85533784 |
113 | Hypoventilation (HP:0002791) | 1.83780213 |
114 | Generalized myoclonic seizures (HP:0002123) | 1.81541849 |
115 | Sudden death (HP:0001699) | 1.81477516 |
116 | Atelectasis (HP:0100750) | 1.81099314 |
117 | Postural tremor (HP:0002174) | 1.80160525 |
118 | Abnormality of the corticospinal tract (HP:0002492) | 1.79744900 |
119 | Impaired vibratory sensation (HP:0002495) | 1.79079289 |
120 | Exercise-induced muscle cramps (HP:0003710) | 1.79045580 |
121 | Syncope (HP:0001279) | 1.78738027 |
122 | Slow progression (HP:0003677) | 1.78327905 |
123 | Myotonia (HP:0002486) | 1.77804076 |
124 | Psychosis (HP:0000709) | 1.77000335 |
125 | Delusions (HP:0000746) | 1.76593386 |
126 | Incomplete penetrance (HP:0003829) | 1.76219679 |
127 | Hammertoe (HP:0001765) | 1.74192877 |
128 | Neuronal loss in central nervous system (HP:0002529) | 1.73843494 |
129 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.73547161 |
130 | Stereotypic behavior (HP:0000733) | 1.73107249 |
131 | Gait ataxia (HP:0002066) | 1.72127614 |
132 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.69351813 |
133 | Anosmia (HP:0000458) | 1.66507378 |
134 | Absent speech (HP:0001344) | 1.66145690 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NTRK3 | 3.92448147 |
2 | MAP3K9 | 3.57369708 |
3 | EPHA4 | 3.35867804 |
4 | PRKD3 | 2.64463777 |
5 | PAK6 | 2.59166529 |
6 | MINK1 | 2.57911581 |
7 | MAP3K4 | 2.52757804 |
8 | MARK1 | 2.52621349 |
9 | KSR2 | 2.34121881 |
10 | DAPK2 | 2.27491991 |
11 | NTRK1 | 1.95283485 |
12 | MAP2K4 | 1.86375456 |
13 | MAP2K7 | 1.82619601 |
14 | PHKG2 | 1.82303261 |
15 | PHKG1 | 1.82303261 |
16 | NTRK2 | 1.76613098 |
17 | CAMKK1 | 1.75483353 |
18 | ARAF | 1.65366575 |
19 | STK38 | 1.52794977 |
20 | CDK5 | 1.46692701 |
21 | KSR1 | 1.41967822 |
22 | UHMK1 | 1.38678387 |
23 | PINK1 | 1.34291455 |
24 | MAP3K12 | 1.34176664 |
25 | LMTK2 | 1.33680782 |
26 | MAP3K2 | 1.31060274 |
27 | GRK5 | 1.29884989 |
28 | TESK1 | 1.25522709 |
29 | PRPF4B | 1.22703901 |
30 | PAK3 | 1.21294986 |
31 | MAPK12 | 1.13403783 |
32 | PRKCG | 1.13236166 |
33 | TAOK1 | 1.11593660 |
34 | WNK3 | 1.07023029 |
35 | SGK223 | 1.06922175 |
36 | SGK494 | 1.06922175 |
37 | PRKCH | 1.04478185 |
38 | TYRO3 | 1.04133029 |
39 | CDK19 | 1.03412721 |
40 | MAP3K13 | 1.03201519 |
41 | CAMKK2 | 1.02753915 |
42 | RET | 1.00371204 |
43 | DAPK1 | 1.00117184 |
44 | MAP3K1 | 0.98170790 |
45 | LATS2 | 0.97865464 |
46 | RIPK1 | 0.96652049 |
47 | RIPK4 | 0.94402176 |
48 | NEK6 | 0.92394227 |
49 | MAPK13 | 0.91585058 |
50 | CAMK2A | 0.88581449 |
51 | CDK14 | 0.87828109 |
52 | CDK18 | 0.86959863 |
53 | WNK4 | 0.85700838 |
54 | CDK15 | 0.85689666 |
55 | FER | 0.85052692 |
56 | CAMK1 | 0.84772128 |
57 | TNIK | 0.83875575 |
58 | SIK2 | 0.83699412 |
59 | CASK | 0.83625818 |
60 | PLK2 | 0.83329088 |
61 | WNK1 | 0.81215351 |
62 | FES | 0.80511888 |
63 | INSRR | 0.78869722 |
64 | PNCK | 0.78588716 |
65 | NEK1 | 0.78522826 |
66 | PKN1 | 0.78250417 |
67 | MAP3K11 | 0.77154252 |
68 | OBSCN | 0.74557586 |
69 | STK11 | 0.74405523 |
70 | CDK11A | 0.74288392 |
71 | PDPK1 | 0.73592356 |
72 | PTK2B | 0.73422214 |
73 | MARK2 | 0.71930729 |
74 | ICK | 0.71671443 |
75 | SGK3 | 0.69445367 |
76 | CAMK2B | 0.69189467 |
77 | OXSR1 | 0.67456327 |
78 | MAPK15 | 0.66824179 |
79 | CAMK1G | 0.65908592 |
80 | PDK1 | 0.65554960 |
81 | DYRK1A | 0.65302575 |
82 | SGK2 | 0.64646637 |
83 | CAMK2D | 0.63752528 |
84 | CAMK2G | 0.62356796 |
85 | CDC42BPA | 0.61826704 |
86 | MAP3K7 | 0.61154717 |
87 | PRKCZ | 0.58625714 |
88 | DAPK3 | 0.58338416 |
89 | ROCK2 | 0.58316978 |
90 | MAP2K1 | 0.57196815 |
91 | RAF1 | 0.56665969 |
92 | TRIB3 | 0.56477529 |
93 | SGK1 | 0.56282431 |
94 | TNK2 | 0.53604872 |
95 | PRKCE | 0.51122336 |
96 | DMPK | 0.50523827 |
97 | RPS6KA3 | 0.49348858 |
98 | CSNK1G2 | 0.48987979 |
99 | ROCK1 | 0.48150369 |
100 | ALK | 0.47055356 |
101 | PDK3 | 0.44970516 |
102 | PDK4 | 0.44970516 |
103 | EEF2K | 0.44888089 |
104 | BRSK1 | 0.43627779 |
105 | MAPK10 | 0.43057896 |
106 | NME1 | 0.42695677 |
107 | RPS6KA2 | 0.42138584 |
108 | CAMK4 | 0.41634511 |
109 | DYRK1B | 0.41490512 |
110 | STK39 | 0.40771917 |
111 | BRAF | 0.40161496 |
112 | BMPR2 | 0.39749972 |
113 | LIMK1 | 0.39130496 |
114 | FYN | 0.38558709 |
115 | MOS | 0.37788695 |
116 | PRKAA1 | 0.35567271 |
117 | MAP2K6 | 0.34744659 |
118 | TAOK2 | 0.33341234 |
119 | ERBB2 | 0.31656033 |
120 | CCNB1 | 0.31594560 |
121 | PRKD1 | 0.31263526 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.22921671 |
2 | Nicotine addiction_Homo sapiens_hsa05033 | 2.87529750 |
3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.57578085 |
4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.43573022 |
5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.40246980 |
6 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.37037607 |
7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.25828362 |
8 | Insulin secretion_Homo sapiens_hsa04911 | 2.24307962 |
9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.15184288 |
10 | Morphine addiction_Homo sapiens_hsa05032 | 2.13437538 |
11 | Long-term potentiation_Homo sapiens_hsa04720 | 2.07197728 |
12 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.00386382 |
13 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.96986218 |
14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.89411767 |
15 | Salivary secretion_Homo sapiens_hsa04970 | 1.80882778 |
16 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.77976773 |
17 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.72803222 |
18 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.68533961 |
19 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.67283140 |
20 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.62842826 |
21 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.61552877 |
22 | Phototransduction_Homo sapiens_hsa04744 | 1.61459855 |
23 | Taste transduction_Homo sapiens_hsa04742 | 1.50552123 |
24 | Cocaine addiction_Homo sapiens_hsa05030 | 1.49640009 |
25 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.45904766 |
26 | Renin secretion_Homo sapiens_hsa04924 | 1.42919585 |
27 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.39853114 |
28 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.35880768 |
29 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.29947938 |
30 | Long-term depression_Homo sapiens_hsa04730 | 1.28963598 |
31 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.27541818 |
32 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.26150083 |
33 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.25870600 |
34 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.20990298 |
35 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.18450150 |
36 | Gap junction_Homo sapiens_hsa04540 | 1.12384322 |
37 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.10423067 |
38 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.06941416 |
39 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.05263872 |
40 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.02162827 |
41 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.99326797 |
42 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.96723691 |
43 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.95835024 |
44 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.92490251 |
45 | Bile secretion_Homo sapiens_hsa04976 | 0.91908956 |
46 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.91494540 |
47 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.88239553 |
48 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.87850665 |
49 | Glioma_Homo sapiens_hsa05214 | 0.85932714 |
50 | Axon guidance_Homo sapiens_hsa04360 | 0.85295148 |
51 | Melanogenesis_Homo sapiens_hsa04916 | 0.84423625 |
52 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.83370951 |
53 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.82616162 |
54 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.81992483 |
55 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.81882125 |
56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.80814117 |
57 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.79227611 |
58 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.78047803 |
59 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.76478271 |
60 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.71779989 |
61 | Circadian rhythm_Homo sapiens_hsa04710 | 0.71185455 |
62 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.71015515 |
63 | Histidine metabolism_Homo sapiens_hsa00340 | 0.69451722 |
64 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.69390487 |
65 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.68226269 |
66 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.66261838 |
67 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.63233824 |
68 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.62823764 |
69 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.61371905 |
70 | Prion diseases_Homo sapiens_hsa05020 | 0.60469881 |
71 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.58219226 |
72 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.56594284 |
73 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.56297157 |
74 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.56225792 |
75 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.55846534 |
76 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.54524111 |
77 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.54085749 |
78 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.52231794 |
79 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.51984672 |
80 | Tight junction_Homo sapiens_hsa04530 | 0.51332759 |
81 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.50937259 |
82 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.50873823 |
83 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.50429036 |
84 | Endocytosis_Homo sapiens_hsa04144 | 0.49839360 |
85 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.49534202 |
86 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48140188 |
87 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.47913732 |
88 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.46942111 |
89 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.43995192 |
90 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.43307145 |
91 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.42526789 |
92 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.40998774 |
93 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.38209007 |
94 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.37900093 |
95 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.37440642 |
96 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.36273865 |
97 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.36262336 |
98 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.36022477 |
99 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.35079148 |
100 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.34692294 |
101 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.34340975 |
102 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.32858998 |
103 | Endometrial cancer_Homo sapiens_hsa05213 | 0.32219567 |
104 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.29057367 |
105 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.28810327 |
106 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.28381408 |
107 | Alzheimers disease_Homo sapiens_hsa05010 | 0.28096919 |
108 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.27879109 |
109 | Alcoholism_Homo sapiens_hsa05034 | 0.27067588 |
110 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.26748847 |
111 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.24749569 |
112 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.24724521 |